Data / Form D filings / QRXPHARMA LTD
QRXPHARMA LTD: Form D filing
QRXPHARMA LTD, a pharmaceuticals company in North Sydney Nsw 2060, filed a Form D with the SEC in 2009. The latest, on December 30, 2009, reports $12.4 million sold of a $12.4 million offering to 526 investors.
Find out what QRXPHARMA LTD does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- LEVEL 1, 194 MILLER STREET, North Sydney Nsw 2060, 00000
- Phone
- 61294928021
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Australia
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1433008
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2009 | New notice | $12,397,760 | $12,397,760 | $0 | 526 | Dec 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gary W. Pace | Director | |
| Peter W. Farrell | Director | |
| John W. Holaday | Director, Executive Officer | |
| Warren W. Stern | Executive Officer | |
| Chris W. Campbell | Executive Officer | |
| Michael W. Quinn | Director | |
| Peter W. Campbell | Director |
Every Form D from the week of Dec 28, 2009 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what QRXPHARMA LTD reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.